doi: 10.1038/nnano.2007.223, 212
Heres how
Indeed, pyridoxal phosphate, the active form of pyridoxine, has been found to have independent neuroprotective potential
Annual medical spending attributable to obesity: Payer- and service-specific estimates
10.1172/JCI117480 J Clin Invest
Similarly, SGLT2 inhibitors have demonstrated robust cardiovascular and renal benefits, including reductions in cardiovascular events and all-cause mortality, with consistent effects across the drug class and irrespective of diabetes status [6, 7] Their metabolic benefitssuch as weight loss, improved lipid profiles, and reduced visceral adipositycontribute to a favourable cardiovascular risk profile, countering the pro-atherogenic state typical of T2DM [8]